001     888244
005     20210304134018.0
024 7 _ |a 10.1039/D0CB00086H
|2 doi
024 7 _ |a 2128/26804
|2 Handle
024 7 _ |a altmetric:88804858
|2 altmetric
024 7 _ |a WOS:000616568300007
|2 WOS
037 _ _ |a FZJ-2020-04793
082 _ _ |a 540
100 1 _ |a Maity, Debabrata
|0 0000-0002-4301-3106
|b 0
|e Corresponding author
245 _ _ |a Sub-stoichiometric inhibition of IAPP aggregation: a peptidomimetic approach to anti-amyloid agents
260 _ _ |a Cambridge
|c 2020
|b The Royal Society of Chemistry
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1610982188_12015
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Membrane-catalysed misfolding of islet amyloid polypeptide is associated with the death of β-cells in type II diabetes (T2D). Most active compounds so far reported require high doses for inhibition of membrane bound IAPP fibrillation. Here, we describe a naphthalimide-appended oligopyridylamide-based α-helical mimetic, DM 1, for targeting membrane bound IAPP. DM 1 completely inhibits the aggregation of IAPP at doses of 0.2 equivalents. DM 1 is also effective at similarly low doses for inhibition of seed-catalyzed secondary nucleation. An NMR based study demonstrates that DM 1 modulates IAPP self-assembly by stabilizing and/or perturbing the N-terminus helix conformation. DM 1 at substoichiometric doses rescues rat insulinoma cells from IAPP-mediated cytotoxicity. Most importantly, 0.2 equivalents of DM 1 disaggregate preformed oligomers and fibrils and can reverse cytotoxicity by modulating toxic preformed oligomers and fibrils of IAPP into non-toxic conformations.
536 _ _ |a 553 - Physical Basis of Diseases (POF3-553)
|0 G:(DE-HGF)POF3-553
|c POF3-553
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Kumar, Sunil
|0 0000-0001-5472-4619
|b 1
700 1 _ |a AlHussein, Ruyof
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Gremer, Lothar
|0 P:(DE-Juel1)145165
|b 3
700 1 _ |a Howarth, Madeline
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Karpauskaite, Laura
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Hoyer, Wolfgang
|0 P:(DE-Juel1)166306
|b 6
700 1 _ |a Magzoub, Mazin
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Hamilton, Andrew D.
|0 0000-0002-0538-175X
|b 8
|e Corresponding author
773 _ _ |a 10.1039/D0CB00086H
|0 PERI:(DE-600)3037398-0
|n 4
|p 225-232
|t RSC chemical biology
|v 1
|y 2020
|x 2633-0679
856 4 _ |u https://juser.fz-juelich.de/record/888244/files/Sub-stoichiometric%20inhibition%20of%20IAPP%20aggregation%3A%20a%20peptidomimetic%20approach%20to%20anti-amyloid%20agents.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:888244
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)145165
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)166306
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-553
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-500
|4 G:(DE-HGF)POF
|v Physical Basis of Diseases
|x 0
914 1 _ |y 2020
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 3.0
|0 LIC:(DE-HGF)CCBYNC3
|2 HGFVOC
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBI-7-20200312
|k IBI-7
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBI-7-20200312
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21